Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis

Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):8S-14S. doi: 10.1097/00000374-200105051-00004.

Abstract

This article represents the proceedings of a symposium at the 2000 ISBRA Meeting in Yokohama, Japan. The presentation was Nonalcoholic fatty liver disease: Implications for alcoholic liver disease pathogenesis, by Anna Mae Diehl.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Endotoxins / adverse effects
  • Fatty Liver / etiology*
  • Fatty Liver / immunology
  • Fatty Liver / pathology
  • Humans
  • Leptin / deficiency*
  • Leptin / immunology
  • Liver / immunology
  • Liver / pathology*
  • Liver Diseases, Alcoholic / etiology*
  • Liver Diseases, Alcoholic / immunology
  • Liver Diseases, Alcoholic / pathology
  • Mice
  • Mice, Obese
  • Mitochondria, Liver / immunology
  • Mitochondria, Liver / metabolism*
  • Necrosis
  • Obesity / immunology
  • Obesity / metabolism
  • Reactive Oxygen Species / immunology
  • Reactive Oxygen Species / metabolism
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Endotoxins
  • Leptin
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha